1. Home
  2. TSQ vs MGNX Comparison

TSQ vs MGNX Comparison

Compare TSQ & MGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TSQ

Townsquare Media Inc.

HOLD

Current Price

$5.34

Market Cap

110.8M

ML Signal

HOLD

Logo MacroGenics Inc.

MGNX

MacroGenics Inc.

HOLD

Current Price

$1.42

Market Cap

94.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSQ
MGNX
Founded
1996
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.8M
94.9M
IPO Year
2000
2013

Fundamental Metrics

Financial Performance
Metric
TSQ
MGNX
Price
$5.34
$1.42
Analyst Decision
Buy
Hold
Analyst Count
2
5
Target Price
$12.50
$3.20
AVG Volume (30 Days)
85.0K
1.4M
Earning Date
11-10-2025
11-12-2025
Dividend Yield
15.07%
N/A
EPS Growth
N/A
N/A
EPS
1.14
N/A
Revenue
$438,695,000.00
$127,626,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.59
N/A
P/E Ratio
$4.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.30
$0.99
52 Week High
$10.39
$3.60

Technical Indicators

Market Signals
Indicator
TSQ
MGNX
Relative Strength Index (RSI) 51.95 45.93
Support Level $4.75 $1.32
Resistance Level $4.98 $1.47
Average True Range (ATR) 0.22 0.08
MACD 0.11 0.00
Stochastic Oscillator 89.00 41.30

Price Performance

Historical Comparison
TSQ
MGNX

About TSQ Townsquare Media Inc.

Townsquare Media Inc is a radio, digital media, entertainment, and digital marketing solutions company principally focused on being the premier local advertising and marketing solutions platform in small and mid-sized markets across the United States. It has three segments which are Subscription Digital Marketing Solutions, Digital Advertising, and Broadcast Advertising. It earns the majority of the revenue from the Broadcasting Advertising segment, which includes its local, regional, and national advertising products and solutions delivered via terrestrial radio broadcast. Its portfolio includes local media brands such as WYRK.com, WJON.com, and NJ101.5.com, and premier national music brands such as XXLmag.com, TasteofCountry.com, UltimateClassicRock.com, and Loudwire.com.

About MGNX MacroGenics Inc.

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. The company has three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload.

Share on Social Networks: